The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders

BACKGROUND: There is evidence that barriers exist for the initiation of direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) for those with substance use disorders (SUDs). However, real world clinical evidence of DAA treatment initiation following receipt of a prescription and continu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xinyi, Song, Hyun Jin, Wang, Wei, Henry, Linda, Childs-Kean, Lindsey M, Re, Vincent Lo, Park, Haesuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244773/
https://www.ncbi.nlm.nih.gov/pubmed/34185563
http://dx.doi.org/10.18553/jmcp.2021.27.7.873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244773/
https://www.ncbi.nlm.nih.gov/pubmed/34185563
http://dx.doi.org/10.18553/jmcp.2021.27.7.873

Ejemplares similares